BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹59 Cr | ₹57 Cr | ₹12 Cr | ₹23 Cr | ₹30 Cr |
What is the latest Contingent Liabilities ratio of BLISS GVS PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹59 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹23 Cr |
| Mar2021 | ₹30 Cr |
How is Contingent Liabilities of BLISS GVS PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹59 Cr | 3.45 | |
| Mar2024 | ₹57 Cr | 390.81 | |
| Mar2023 | ₹12 Cr | -48.95 | |
| Mar2022 | ₹23 Cr | -25.09 | |
| Mar2021 | ₹30 Cr | - | |
Compare Contingent Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,808.0 Cr | 9.8% | 12.6% | 1.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 9.8% |
12.6% |
1.9% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses